The Economic and Public Health Consequences of Declining Flu Vaccination Rates
Seasonal influenza imposes a recurring, massive, and largely preventable macroeconomic toll. Despite the proven clinical efficacy of the influenza vaccine in reducing viral transmission, hospitalizations, and mortality, national adult vaccination rates have experienced a 24% decline between the 2020–2021 and 2024–2025 flu seasons.
This downward trajectory is particularly severe in the Southern United States, a region that consistently records the lowest immunization rates in the country across multiple respiratory viruses.
The $29 Billion Burden
During the 2023–2024 influenza season alone, the disease cost the U.S. economy an estimated $29 billion, driven by $16 billion in direct medical expenditures and $13 billion in lost productivity due to absenteeism and premature mortality. Southern states bear a disproportionately high share of these economic damages, driven by:
- Higher baseline rates of uninsurance
- Greater prevalence of chronic comorbidities
- Deeply entrenched racial disparities in healthcare access
- Restrictive regulations limiting pharmacist vaccination authority
The Widening Geographic Gap
The national adult influenza vaccination rate stood at just 46.7% for the 2024–2025 season. However, this aggregate figure obscures deep regional divides. The Southern United States dominates the bottom tier of national immunization rankings.
| State | 24-25 Rate | 23-24 Rate | YoY Change | Regional Context |
|---|---|---|---|---|
| Georgia | 38.6% | 39.5% | -0.9% | Bottom 5 Nationally |
| Alabama | 39.1% | 40.3% | -1.2% | Bottom 5 Nationally |
| South Carolina | 43.4% | 45.6% | -2.2% | Below National Average |
| North Carolina | 46.6% | 48.6% | -2.0% | Below National Average |
| Tennessee | 42.7% | 44.3% | -1.6% | Below National Average |
| National Average | 46.7% | 47.4% | -0.7% | N/A |
Cost Implications of Healthcare Utilization
| Resource Category | Annual National Volume | Average Cost Implications |
|---|---|---|
| Outpatient Medical Visits | 18 to 31.4 Million | Averages $6.8 Billion annually |
| Inpatient Hospitalizations | 247,000 to 470,000 | Mean per-patient cost: $11,384 to $14,494 |
| Premature Mortality | 28,000 to 41,000 | Primary driver of statistical life value and human capital losses |
By The Numbers: The Macroeconomic Impact
National Toll
Seasonal flu cost the U.S. economy an estimated $29 billion last season alone: $16 billion in medical costs, $13 billion in lost productivity. Most of it was preventable.
The Southern Gap
While New England routinely tops 60% adult flu vaccination, Southern states dominate the bottom of the national rankings. The gap is widening every season.
Cost of Hospitalization
The average cost of a single flu hospitalization and ER visit, per patient. Multiply that across hundreds of thousands of cases a season, straining every hospital budget in the South.
Post-Infection Value
Adults hospitalized with flu who got vaccinated beforehand had significantly better outcomes than those who didn't, even though they still got sick.
Who Can Afford to Stay Home
Only 13% of low-income workers believe they could afford to stay home sick with the flu — compared to 44% of high-income workers. Without paid sick leave, illness spreads because people can't afford not to work.
State-Specific Advocacy Snapshots
Georgia
Bottom 5 Nationally
Talking Point
"Georgia's flu vaccination rate is falling faster than most of the country: and every point of decline shows up as ER visits and lost workdays that Georgia employers and hospitals absorb."
Alabama
Bottom 5 Nationally
Talking Point
"Alabama saw the sharpest single-year decline in adult flu vaccination in the region. At current trajectory, the state is on track for even deeper losses next season, losses that land on rural hospitals already operating on thin margins."
South Carolina
Below National Average
Talking Point
"South Carolina's flu vaccination rate dropped more than two full points in a single year. That's not a statistical blip; it's thousands of additional preventable cases moving through the state's healthcare system."
North Carolina
Below National Average
Talking Point
"North Carolina is nearly at the national average, meaning targeted investment now could put the state ahead of the national trend instead of falling further behind it."
Tennessee
Below National Average
Talking Point
"Tennessee's flu vaccination rate continues to slide even as hospitalization costs climb. Expanding pharmacist vaccination access is one of the lowest-cost levers available to reverse that trend."
Actionable Policy Recommendations
By dismantling restrictive regulatory barriers that limit pharmacist scope of practice, rejecting preemption laws that stifle local public health interventions, and implementing strategic, equity-focused immunization initiatives, Southern states can avert thousands of premature deaths and reclaim hundreds of millions of dollars in lost economic output each season.